These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25036352)

  • 1. Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.
    Tang L; Chen B; Ma B; Nie S
    Genet Mol Res; 2014 Jun; 13(2):4473-85. PubMed ID: 25036352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus.
    Hu W; Ren H
    Int J Immunogenet; 2011 Oct; 38(5):411-7. PubMed ID: 21834935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
    Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
    Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
    Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts.
    Nordang GB; Viken MK; Amundsen SS; Sanchez ES; Flatø B; Førre OT; Martin J; Kvien TK; Lie BA
    Rheumatology (Oxford); 2012 Apr; 51(4):619-26. PubMed ID: 22179739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis.
    Dieguez-Gonzalez R; Calaza M; Perez-Pampin E; de la Serna AR; Fernandez-Gutierrez B; Castañeda S; Largo R; Joven B; Narvaez J; Navarro F; Marenco JL; Vicario JL; Blanco FJ; Fernandez-Lopez JC; Caliz R; Collado-Escobar MD; Carreño L; Lopez-Longo J; Cañete JD; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2008 May; 58(5):1264-74. PubMed ID: 18438842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
    Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
    Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.
    Carmona FD; Martin JE; Beretta L; Simeón CP; Carreira PE; Callejas JL; Fernández-Castro M; Sáez-Comet L; Beltrán E; Camps MT; Egurbide MV; ; Airó P; Scorza R; Lunardi C; Hunzelmann N; Riemekasten G; Witte T; Kreuter A; Distler JH; Madhok R; Shiels P; van Laar JM; Fonseca C; Denton C; Herrick A; Worthington J; Schuerwegh AJ; Vonk MC; Voskuyl AE; Radstake TR; Martín J
    PLoS One; 2013; 8(1):e54419. PubMed ID: 23372721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome.
    Miceli-Richard C; Comets E; Loiseau P; Puechal X; Hachulla E; Mariette X
    Arthritis Rheum; 2007 Dec; 56(12):3989-94. PubMed ID: 18050197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus.
    Hammad A; Mossad YM; Nasef N; Eid R
    Lupus; 2017 Jul; 26(8):871-880. PubMed ID: 28059021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of rs10954213 polymorphisms and haplotype diversity in interferon regulatory factor 5 with systemic lupus erythematosus: a meta-analysis.
    Liu HF; An XJ; Yang Y; Yang L; Li Y; Huang CZ; Tao J; Tu YT
    J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):15-21. PubMed ID: 23392701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis.
    Rueda B; Reddy MV; González-Gay MA; Balsa A; Pascual-Salcedo D; Petersson IF; Eimon A; Paira S; Scherbarth HR; Pons-Estel BA; González-Escribano MF; Alarcón-Riquelme ME; Martín J
    Arthritis Rheum; 2006 Dec; 54(12):3815-9. PubMed ID: 17133578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.
    Shimane K; Kochi Y; Yamada R; Okada Y; Suzuki A; Miyatake A; Kubo M; Nakamura Y; Yamamoto K
    Ann Rheum Dis; 2009 Mar; 68(3):377-83. PubMed ID: 18408250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.
    Tang L; Wan P; Wang Y; Pan J; Wang Y; Chen B
    Inflamm Res; 2015 Oct; 64(10):817-24. PubMed ID: 26294277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of interferon regulatory factor 5 (IRF5) markers with an increased risk of lupus and overlapping autoimmunity in a Kuwaiti population.
    AlFadhli S; Jahabani I
    Ann Hum Biol; 2014; 41(6):531-9. PubMed ID: 24697591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the FAM167A-BLK region with systemic sclerosis.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2010 Mar; 62(3):890-5. PubMed ID: 20131239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The
    Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
    Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.